AARA News
This Implant is the 1st Non-drug Therapy for Rheumatoid Arthritis Patients
Rheumatoid arthritis is one of the chronic diseases caused by inflammation. It’s a painful, life-altering condition — and recently, the FDA approved a new treatment for it that Dr. John Tesser says has the potential to drastically improve patients’ quality of life.
It’s called SetPoint therapy — named for the company that created it, SetPoint Medical.
It’s a tiny, pill-sized implant that’s inserted into the body. Tesser is a rheumatologist here in the Valley, and a professor at University of Arizona’s medical school. He served as the national principal investigator during the trial period for Setpoint therapy.
Tesser told The Show that the implant works by stimulating the vagus nerve in the neck, which then sends signals into the spleen.
Listen to the full article or read the full transcript on KJZZ Phoenix.
Future Outcomes of First-Line TNFi After Initial Nonresponse
A recent study conducted by experts in Rheumatology, including AARA’s John R. P. Tesser, MD, FACP, FACR, MACR, looked at patients with rheumatoid arthritis (RA) who started taking a medication used to treat RA, a tumor necrosis factor inhibitor (TNFi).
Overall, the study showed that if patients treated with a TNFi did not improve initially, they were unlikely to improve later, and that nearly a quarter of patients who improved initially with a TNFi saw their condition worsen.
Find the full publication here:
Real-World Analysis of Initial Clinical Response and Future Outcomes Among Patients with Rheumatoid Arthritis Initiating and Remaining on a First-Line Tumor Necrosis Factor Inhibitor in the United States
A Surprising New Treatment for Rheumatoid Arthritis
LISTEN: A Surprising New Treatment for Rheumatoid Arthritis on All Things Considered
The Food and Drug Administration (FDA) has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis. Listen in as the first patient to get this device describes her experience with vagus nerve stimulation.
This newly approved treatment comes on the heels of research conducted by AARA’s own John R. P. Tesser, MD, FACP, FACR, MACR, and AARA Clinical Research. Dr. Tesser spoke with NPR’s Jon Hamilton to provide a clinical research perspective on the new device made by SetPoint Medical.
This treatment is utilizing the body’s own mechanism of managing inflammation.
Find the original interview on NPR’s All Things Considered >
Click here to learn more about the pivotal study that helped usher in this new RA treatment.
In the summer of 2019, just after her 30th wedding anniversary, Lynn Milam’s life took a sudden turn.
LYNN MILAM
I had bent down in front of my kitchen sink and noticed this unusual pain in my knees.
JON HAMILTON
It was the first sign of rheumatoid arthritis, which occurs when the immune system starts attacking the lining of joints. Milam says, pretty soon, everything hurt.
MILAM
My back, my knees, my ankles, my shoulders, my neck, my whole body had become affected.
JON HAMILTON
Milam tried physical therapy, acupuncture, steroids, and even the latest costly immune drugs. Nothing worked. Stairs were a no-go. Even a gentle touch sent pain radiating throughout her body.
MILAM
My children could not hug me. You know, I couldn’t hold my husband’s hand.
JON HAMILTON
So, when her rheumatologist suggested a clinical trial, Milam said yes. The trial involved a device that delivers pulses of electricity to the vagus nerve, which carries signals between the brain and internal organs. Dr. Peter Konrad, a neurosurgeon at West Virginia University, was part of a nationwide study of the device.
PETER KONRAD
It’s the size of a lima bean. I mean, that’s cool when you think about an implant. It doesn’t have wires going places. Everything’s all built on a little chip. And then it’s contained in a little silicone jacket.
JON HAMILTON
The stimulator, made by Setpoint Medical, is placed through a small incision in the neck. Conrad says it’s a lot like devices used to control epileptic seizures.
KONRAD
Neurosurgeons have been putting vagus nerve stimulators in for epilepsy for two decades. So, it’s not like we didn’t know how to put a device on the vagus nerve.
JON HAMILTON
For Milam, the operation itself was easy.
MILAM
I’ve had dental surgery that was more of a process than this surgery was.
JON HAMILTON
There was a hitch, though. Because the device sits so close to the vocal cords, Milam’s voice was temporarily limited to a whisper. A second procedure fixed that but left her voice slightly lower than it had been. Milam says she’ll accept that for a treatment that did what drugs could not.
MILAM
Three weeks in, my elbow pain was completely gone. Then my hands. My hands didn’t hurt anymore. The swelling started going away. Everything started, like, going away.
JON HAMILTON
The idea that electrical impulses could alter the immune system was not immediately embraced by the medical community. Dr. John Tesser is a rheumatologist in Phoenix.
JOHN TESSER
I, like probably all of my colleagues, was somewhat skeptical.
JON HAMILTON
Then Tesser began to look at how the device works. By stimulating the vagus nerve, it activates a reflex in the brain. That reflex instructs cells in the spleen to stop making inflammatory proteins called cytokines.
TESSER
This treatment is utilizing the body’s own mechanism of managing inflammation.
JON HAMILTON
It rarely produces the sort of recovery that Lynn Milam experienced. But Tesser says the pivotal clinical trial found that patients who had not responded to even the most powerful drugs often saw meaningful improvement.
TESSER
Thirty-five percent of the patients did achieve that in this very difficult-to-treat group.
JON HAMILTON
Significantly more than in a comparison group whose stimulators had not yet been switched on. Tesser says rheumatoid arthritis may be just the first disease treated by stimulating the vagus nerve.
TESSER
There are implications for all kinds of systemic autoimmune diseases. So, we’re talking multiple sclerosis, psoriatic arthritis, and inflammatory bowel disease, just to name a few.
JON HAMILTON
For Lynn Milam, the stimulator has restored her ability to climb stairs, cook, and travel. It’s also restored a bond with her husband, Donnie, who wanted to celebrate her recovery by renewing their vows.
MILAM
So that’s what we did. And that night, to me, meant more than our wedding. It was like a rebirth of everything.
JON HAMILTON
Donnie Milam says he’s just happy to be back doing everyday activities with his wife.
DONNIE MILAM
Walking the dogs, holding hands, just the simple things, and hugs.
JON HAMILTON
Jon Hamilton, NPR News.
Proud Sponsors of the Arthritis Foundation – Walk to Cure Arthritis
AARA proudly participated in this year’s Walk to Cure Arthritis, joining the community in raising awareness and support for those living with arthritis. Our team of providers, staff, patients, and families walked together in solidarity and celebration of progress in arthritis care. The event raised a grand total of $172,064 to support vital services and scientific research. We’re honored to have been part of such an inspiring event!






